Page 65 - SaxoCell Annual Report22/23

The workshop covered all important topics from
biostatistics (Dirk Hasenclever) to GMP-compliant ATMP
production (Jörg Schäffner, IDT Biologika GmbH) and
regulatory requirements. With experts from the Paul
Ehrlich Institute PEI (Bettina Ziegele), the Landesdirektion
Sachsen (Anne Lewerenz), the Koordi-nierungszentrum für
Klinische Studien KKS Dresden (Xina Grählert) and the
Zentrum für Klinische Studien ZKS Leipzig (Peggy Houben)
we spent two intensive days with very valuable input. An
important further step to support the translation of our
cell and gene therapy projects into the clinic has been
Organizer Silke Gloaguen during
moderation taken.
Many scientists from the cluster, such as
Vladan Vucinic (SaxoCell project ECP-CAR,
PhotoCAR study), but also from outside, such
as Catharina Schütz (transplantation of
thymus tissue) and Ralf Henkelmann (solutions
for cartilage damage) presented their projects
clearly in the form of case studies and were
thus able to give the participants a good
insight into current clinical issues. In addition,
the workshop provided ample opportunity for
discussion and networking both within and
outside the sessions. Afterwards, the SaxoCell regulars' table at the end of the CLINICs
discussions could be deepened at the SaxoCell workshop
regulars' table.

60